Showing results (61-70 of 437) with videos related to
Sort By:
Pageof 44
Trends in Pharmacological Sciences|May 8, 2001
Therapeutic modulation of transcription factor activityJ G Emery, E H Ohlstein, M JayeThe EMBO Journal|May 1, 1989
Differential signalling potential of insulin- and IGF-1-receptor cytoplasmic domainsR Lammers, A Gray, J Schlessinger, et al.The Journal of Biological Chemistry|December 6, 1996
Induction of urokinase-type plasminogen activator by fibroblast growth factor (FGF)-2 is dependent on expression of FGF receptors and does not require activation of phospholipase Cgamma1M Roghani, M Mohammadi, J Schlessinger, et al.The Journal of Biological Chemistry|October 25, 1982
Inhibition of peptide initiation by a low molecular weight RNA from rabbit reticulocytesC A Dionne, G B Stearns, G Kramer, et al.The Journal of Biological Chemistry|June 24, 1994
Internalization of fibroblast growth factor receptor is inhibited by a point mutation at tyrosine 766A Sorokin, M Mohammadi, J Huang, et al.Molecular and Cellular Biology|July 1, 1994
GRB2 and phospholipase C-gamma 1 associate with a 36- to 38-kilodalton phosphotyrosine protein after T-cell receptor stimulationM Sieh, A Batzer, J Schlessinger, et al.Science (New York, N.Y.)|August 9, 1996
Activation of Pyk2 by stress signals and coupling with JNK signaling pathwayG Tokiwa, I Dikic, S Lev, et al.Endocrinology|August 1, 1982
The interaction of cultured thyroid cells of early bovine embryos with thyrotropin and thyroglobulinA Avivi, J Schlessinger, M Shemesh, et al.The EMBO Journal|September 1, 1986
Mutations in the cytoplasmic domain of EGF receptor affect EGF binding and receptor internalizationR Prywes, E Livneh, A Ullrich, et al.Journal of Basic and Clinical Physiology and Pharmacology|July 1, 1991
Interaction of epidermal growth factor with vasoactive hormones in the regulation of phospholipase A2N Hack, B Margolis, J Schlessinger, et al.Pageof 44